肝素样效应与重型酒精相关性肝炎出血、脓毒症及死亡风险相关
在印度单中心前瞻性纳入78例无脓毒症的重型酒精相关性肝炎男性患者,于第0、3、7天检测肝素样效应(HLE)及凝血指标并随访28天。第0天HLE见于32例(41%),与脓毒症、出血及死亡风险升高相关;多因素分析仅因子VIII活性、INR、蛋白C水平及MELD评分与死亡相关。
要点
- 重型酒精相关性肝炎患者第0天HLE检出率为41%(32/78)。
- 第0天HLE增加脓毒症(HR 2.5)、出血(HR 1.4)及死亡(HR 1.2)风险。
- 多因素分析中因子VIII活性、INR、蛋白C及MELD评分与死亡相关。
核心结论
- 在重型酒精相关性肝炎患者中,HLE与凝血异常、脓毒症风险及死亡率相关。
研究设计与样本
- 前瞻性研究,最终分析纳入78例重型酒精相关性肝炎患者(44.3±11.7岁,均为男性,判别函数>32),来自印度单中心,2015年8月至2016年8月就诊时无脓毒症。
- 于就诊后第0、3、7天采集血样,行整体凝血试验、SONOCLOT(整体及肝素酶处理)及因子VIII、血管性血友病因子、蛋白C、抗凝血酶检测,随访脓毒症、出血及结局。
- 主要结局为HLE与就诊后28天生存的关联。
主要发现
- HLE在第0天见于32例(41%),第3天27例(34.6%),第7天28例(35.9%)。
- 第0天与死亡相关的因素:因子VIII活性>160%(HR 3.1,95%CI 1.4-9.5,P=.026)、蛋白C水平<34%(HR 0.7,95%CI 0.5-0.8,P=.037)、抗凝血酶活性<28%(HR 0.7,95%CI 0.3-1.1,P=.008)、INR>2.6(HR 2.3,95%CI 1.8-9.7,P=.010)。
- 多因素分析中仅因子VIII活性(HR 2.3,95%CI 1.6-7.8,P=.046)、INR(HR 1.9,95%CI 1.2-4.3,P=.039)、蛋白C水平(HR 0.9,95%CI 0.7-1.1,P=.052)及MELD评分(HR 3.2,95%CI 1.9-10.2,P=.042)与死亡相关。
- 鼻出血、痔疮出血、腹腔积血及肺出血发生率分别为10.2%、12.3%、3.4%、4.5%。
- 第0天存在HLE增加脓毒症风险(HR 2.5,95%CI 2.2-4.3,P=.002)、出血风险(HR 1.4,95%CI 1.2-5.3,P=.004)及死亡风险(HR 1.2,95%CI 1.4-1.7,P=.044)。
关键数值与推荐
- HLE定义采用SONOCLOT肝素酶处理前后整体凝血试验的差异进行判断。
- 判别函数>32定义重型酒精相关性肝炎。
- 主要结局为就诊后28天生存。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Endogenous heparinoids or heparin-like effects (HLEs) can cause coagulation failure in patients with cirrhosis and sepsis. We performed a prospective study of the association between HLE and bleeding events, sepsis, and outcomes of patients with severe alcohol-associated hepatitis. METHODS: Our final analysis comprised 78 patients with severe alcohol-associated hepatitis (44.3 ± 11.7 years; all male; discriminant function >32) who presented without sepsis at a single center in India from August 2015 through August 2016. Blood samples were collected at days 0, 3, and 7 after presentation and assessed by a global coagulation assay; by SONOCLOT (global and heparinase treated); and in assays for factor VIII, von Willebrand factor, protein C, and antithrombin. Patients were followed for sepsis, bleeding and outcome. The primary outcome was association of HLE with survival 28 days after presentation. RESULTS: HLEs were observed in 32 patients (41%) at day 0, 27 patients (34.6%) at day 3, and 28 patients (35.9%) patients at day 7. Factors associated with mortality at day 0 were factor VIII activity >160% (hazard ratio [HR], 3.1; 95% CI, 1.4-9.5; P = .026), level of protein C <34% (HR, 0.7; 95% CI, 0.5-0.8; P = .037), antithrombin activity <28% (HR, 0.7; 95% CI, 0.3-1.1; P = .008) and international normalized ratio >2.6 (HR, 2.3; 95% CI, 1.8-9.7; P = .010). In multivariate analyses, only factor VIII activity (HR, 2.3; 95% CI, 1.6-7.8; P = .046), international normalized ratio (1.9; 95% CI, 1.2-4.3; P = .039), level of protein C (HR, 0.9; 95% CI, 0.7-1.1; P = .052) and model for end-stage liver disease score (HR, 3.2; 95% CI, 1.9-10.2; P = .042) were associated with mortality. Episodes of epistaxis, hemorrhoid bleeding, hemoperitoneum, and pulmonary hemorrhage occurred in 10.2%, 12.3%, 3.4%, and 4.5% of patients respectively. The presence of HLE at day 0 increased the risk of sepsis (HR, 2.5; 95% CI, 2.2-4.3; P = .002), bleeding (HR, 1.4; 95% CI, 1.2-5.3; P = .004) and death (HR, 1.2; 95% CI, 1.4-1.7; P = .044). CONCLUSIONS: In a prospective study of patients with severe alcohol-associated hepatitis, we associated HLE with coagulation abnormalities, risk of sepsis, and mortality. Clinicaltrials.govNCT02307409.
引用
- Premkumar M, Bihari C, Saxena P, et al. Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis. Clin Gastroenterol Hepatol. 2019. PMID: 31077821. doi:10.1016/j.cgh.2019.04.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。